Mitral Valve Stenosis: Clinical Trials

4 trials for Mitral Valve Stenosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Unknown 2, Completed 1, Terminated 1

Follow Mitral Valve Stenosis: new trials by email Literature Review of Mitral Valve Stenosis trials Research Report on Mitral Valve Stenosis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dapagliflozin Effect on Rheumatic Mitral Stenosis
Dapagliflozin - Rheumatic Heart Disease, Heart Failure
Phase 3UnknownUniversitas Sebelas Maret362022-12-012022-11-21
The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients
Placebos, Ramipril 5Mg Oral Capsule - Rheumatic Heart Disease, Mitral Stenosis
Phase 3UnknownUniversitas Indonesia662019-06-272021-08-16
RIvoraxaban in Mitral Stenosis
Rivaroxaban, Warfarin - Mitral Stenosis, Rheumatic Heart Disease
Phase 3TerminatedRajaie Cardiovascular Medical and Research Center402019-05-222021-08-19
Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm
Ivabradine, Atenolol - Mitral Stenosis
Phase 3CompletedGovind Ballabh Pant Hospital502009-11-012011-07-07

Narrower conditions

Rheumatic Heart Disease (3)  ·  Atrial Fibrillation (1)  ·  Fibrosis (1)  ·  Heart Failure (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Heart Diseases (4)  ·  Heart Valve Diseases (4)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Positive Bacterial Infections (3)  ·  Infections (3)  ·  Rheumatic Fever (3)  ·  Streptococcal Infections (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Arrhythmias, Cardiac (1)

Interventions

Atenolol (1)  ·  Control Groups (1)  ·  Ivabradine (1)  ·  Ramipril (1)  ·  Rivaroxaban (1)  ·  Warfarin (1)  ·  dapagliflozin (1)

Sponsors

Govind Ballabh Pant Hospital (1)  ·  Rajaie Cardiovascular Medical and Research Center (1)  ·  Universitas Indonesia (1)  ·  Universitas Sebelas Maret (1)

Countries

Indonesia (2)  ·  India (1)  ·  Iran (1)

Top investigators

Ade Meidian Ambari, MD,FIHA (1)  ·  An Aldia Asrial, MD (1)  ·  Dr Neeraj Parakh, MD, DM (1)  ·  Majid Maleki, M.D. (1)

Results publications

PMID 34518254, PMID 35306032